Xifaxan 550 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FVJLR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,482
Award facts
- Contract value 100% obligated
- $42,481.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Xifaxan 550 mg tablets in quantities of 60 units under a firm fixed-price contract. The order, valued at $42,481.75, was awarded without set-aside restrictions through open competition, reflecting the vendor's established capability to meet federal pharmaceutical procurement requirements. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains a substantial portfolio of pharmaceutical deliveries primarily through the Defense Logistics Agency and its Medical Supply Chain. The company is registered in the System for Award Management and has demonstrated consistent capability in fulfilling diverse federal medical supply needs through competitively awarded contracts with firm fixed pricing structures. This particular order supports the company's ongoing role in supplying specialized pharmaceuticals and medical commodities to military and veteran healthcare systems as part of the DLA's broader strategy to maintain adequate pharmaceutical inventories through multiple qualified prime vendors.
Quick answers
Who was awarded contract SPE2DB25FVJLR?
SPE2DB25FVJLR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FVJLR worth?
The government has obligated $42,482 on SPE2DB25FVJLR.
Is contract SPE2DB25FVJLR an order under another contract?
Yes. SPE2DB25FVJLR is a delivery order under SPE2DB25D3017, an indefinite delivery contract.
Was contract SPE2DB25FVJLR competed?
The extent of competition for SPE2DB25FVJLR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award